Bergamot (Citrus bergamia)

Nomenclature & Taxonomic Classification

• Botanical Binomial: Citrus bergamia (Risso & Poit.)
• Family: Rutaceae
• Common Name(s): Bergamot, Bergamot Orange, Prince’s Pear
• Parts Used: Fresh fruit peel (cold-pressed essential oil) and whole fruit extract/juice.

Botanical Description, Habitat & Sustainability

• Physical Description: * Growth Habit: Small, evergreen tree growing up to 3–4 meters in height.
  • Morphology: Ovate, dark-green leaves with winged petioles; small white flowers that yield a round, slightly pear-shaped citrus fruit that ripens from green to a smooth yellow peel.
• Habitat & Cultivation: Native to Southern Europe; almost exclusively cultivated in the coastal Calabria region of Southern Italy due to its highly specific microclimate (calcareous, alluvial soils with intense sun and maritime winds).
• Sustainability Status: Cultivated agricultural crop; stable. No wild population threats, though highly vulnerable to regional climate shifts in Calabria.

Energetics & Traditional Actions

• Western Tissue States: Corrects Constriction/Tension (relaxes spasmodic states) and Torpor/Stagnation (stimulates circulatory and metabolic movement).
• Traditional Vector:
  • Ayurveda: Rasa (Taste): Tikta (Bitter), Amla (Sour) | Virya (Energy): Ushna (Heating) | Vipaka (Post-Digestive Effect): Katu (Pungent) | Dosha Modulation: Pacifies Vata and Kapha; elevates Pitta in excess.
  • Traditional Chinese Medicine: Temperature: Cool to Neutral | Taste: Acrid, Bitter, Sour | Organ Meridians Entered: Liver, Spleen, Stomach
• Historical Folk Use: Historically utilized in Italian folk medicine for malaria-associated fevers, intestinal parasites, and as an aromatic antiseptic wash for skin infections and wound healing.

Phytochemistry & Pharmacological Dynamics

• Primary Phytochemicals: Volatile monoterpenes (limonene 30–45%, linalyl acetate 20–35%, linalool); furanocoumarins (bergapten, bergamottin); flavanone glycosides (neoeriocitrin, naringin, neohesperidin); unique statin-like flavanones (brutieridin, melitidin).
• Mechanism of Action: > The volatile fractions (linalool and linalyl acetate) alter nervous system activity by modulating GABA-A receptors, inducing anxiolysis and reducing salivary cortisol without motor impairment. Systemically, the polyphenolic fraction downregulates HMG-CoA reductase (via brutieridin and melitidin mimicking endogenous substrates), effectively blocking hepatic cholesterol synthesis and inducing LDL-receptor expression similarly to pharmaceutical statins. Furthermore, it activates AMP-activated protein kinase (AMPK), improving peripheral insulin sensitivity and glucose transport.

Clinical Applications & Indications

• Primary Indications: Hyperlipidemia (elevated LDL, hypertriglyceridemia), metabolic syndrome, endothelial dysfunction, generalized anxiety disorder (GAD), and stress-induced insomnia.
• Secondary Indications: Dyspepsia, spasmodic digestive complaints, mild depressive states, and topical tinea infections.
• Modern Clinical Evidence: Multiple randomized, double-blind, placebo-controlled human trials show that 500–1000 mg daily of Bergamot Polyphenolic Fraction (BPF) significantly reduces total cholesterol, LDL-C, and triglycerides while increasing HDL-C. Aromatherapy trials confirm acute inhalation drops serum cortisol levels and reduces autonomic nervous system stress markers.

Preparation, Dosing & Extraction Matrix

• Optimal Menstruum & Extraction Guidelines: Essential oil extracted via cold expression of the fresh pericarp. Polyphenolic extracts optimized via aqueous-alcoholic extraction (40–60% EtOH) of the juice and albedo to concentrate flavanone glycosides.

Standard Dosage Parameters

Safety Profile, Contraindications & Drug Interactions

• Contraindications: Pregnancy and lactation (for high-dose oral extracts due to lack of safety data). Cold-pressed essential oil is strictly contraindicated on skin exposed to UV radiation.
• Side Effects & Toxicity Thresholds: Generally safe. Cold-pressed bergamot oil contains furanocoumarins (bergapten) which are highly phototoxic; topical application can induce severe phytophotodermatitis (blistering and hyperpigmentation) if exposed to sunlight within 24 hours. Oral use of extracts may cause mild GI distress or hypoglycemia in highly sensitive individuals.
• Pharmaceutical Cross-Interactions: * Enzyme Alterations: Bergamottin is a known potent inhibitor of intestinal CYP3A4; concurrent intake can increase serum levels of drugs metabolized by this pathway (e.g., specific statins, calcium channel blockers).
  • Additive Pathways: May exhibit additive lipid-lowering effects with HMG-CoA reductase inhibitors (statins) and additive blood-glucose-lowering effects with oral hypoglycemic agents.

References

1. Mattioli, P. A. (1544). Pedacii Dioscoridis Anazarbei de Medica Materia Libri Sex.
2. Skinner, M. (2022). Clinical Aromatherapy and Therapeutics (4th ed.).
3. Mollace, V., et al. (2011). Hypoglycemic and hypolipidemic effects of Citrus bergamia polyphenols: From animal models to human studies. Fitoterapia, 82(3), 309-316.